Form 4: Assembly Biosciences Director Alexander Schornstein Increases Stake in Company

Alexander Schornstein, a director at Assembly Biosciences, recently purchased additional shares of the company's common stock in open market transactions.

Summary

• On July 3, 2024, Alexander Schornstein purchased 4,562 shares of Assembly Biosciences common stock at a weighted average price of $12.29.
• These shares were bought in multiple transactions with prices ranging from $11.99 to $12.40.
• Following this transaction, Schornstein directly owns 688,675 shares.
• On July 5, 2024, Schornstein further increased his holdings by purchasing 4,438 shares at a weighted average price of $12.52.
• These shares were bought in multiple transactions with prices ranging from $12.40 to $12.68.
• After the second purchase, Schornstein's direct ownership increased to 693,113 shares.
• The purchases were made using personal funds in the open market.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's prospects. However, it's a single data point and should be considered alongside other factors.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as it can provide insights into management's perspective on the company's valuation and future performance. It's a common practice and is regulated by the SEC to prevent insider trading.

Stakeholder Impact

• Shareholders may view the insider buying as a positive signal.
• The increased ownership by a director aligns their interests more closely with those of other shareholders.

Key Dates